Medical bioreactor market was valued at US$ 4.31 billion in 2024 and is projected to hit the market valuation of US$ 7.04 billion by 2033 at a CAGR of 5.80% during the forecast period 2025–2033.

The Rocking Bioreactors Market is expected to grow at a CAGR of 14.8% during the forecast period. This growth is driven by the increasing demand for biotherapeutics and advancements in cell culture ...

Prolific recently completed the world’s largest demonstration of optogenetics at 200L-scale in a stainless steel bioreactor. About Prolific Machines ...

The 200-liter run is also the first demonstration of optogenetics in a stainless-steel bioreactor. The milestone highlights the company’s ability to deliver optogenetics benefits to biopharma ...

The AAV commercial manufacturing facility features two production lines with 50/200L and 500L bioreactors that comply with both China GMP and US cGMP standards.

ReiThera's core manufacturing capacity is based in a state-of-the-art facility, which includes stirred-tank bioreactors at scales of 50L, 200L, 1000L, and 2000L, as well as fixed-bed bioreactors for ...

During a tour of the facility, members of the press were shown the site's integrated process development and analytical labs and the four GMP cleanrooms, each equipped with up to 2 x 200L bioreactors ...

The facility is designed to accommodate scale-up, optimization, and manufacture of cell therapies, RNA therapies, and viral vectors, with up to 2 x 200L bioreactors and multiple autologous cell ...

It can support scale-up, optimisation and manufacture of cell therapies, RNA therapies and viral vectors, with up to 2 x 200L bioreactors and multiple autologous cell therapy stations per suite. In ...

Single-use technologies are widely adopted across WuXi Biologics’ global manufacturing network, at scales ranging from 200L to 4,000L. The new 5,000L single-use bioreactors at MFG20 are expected ...